InforSense and Spotfire have reported a new three-way alliance and collaboration with GlaxoSmithKline (GSK) to drive innovation in discovery application management
InforSense, Spotfire, and GlaxoSmithKline say they intend to reduce the time to build and manage decision support applications.
The collaboration is leading to a joint offering where Spotfire and InforSense users can take advantage of the two closely integrated technologies; utilising assets in both systems in development and roll-out of applications.
"GlaxoSmithKline has an ongoing investment in research - including people, research facilities, innovative science and IT," commented Stephen Calvert, vice president of cheminformatics at GSK.
"We have invested over the last years in web services interfaces to a large set of computational and data assets - and now with the joint system from Spotfire and InforSense we can rapidly manage, orchestrate, and deliver to end-users applications at the pace of discovery".
"This is a remarkable collaboration involving a unique opportunity to take the expertise from a large organisation like GSK with wide experience in building web services to scientific systems, Spotfire with deep expertise in visual analytic applications and our expertise in workflow based integrative analytics - and apply them to create a novel system for rapid application building," said Yike Guo, CEO of InforSense.
"The promise of effectively orchestrating web services, disparate data sources, and interactive end-user applications across a large enterprise is remarkable - and could fundamentally change the speed and effectiveness of IT in discovery and other key business processes - we think we have an opportunity to achieve that here," said Christopher Ahlberg, CEO of Spotfire.
